3 projects
Core technology across all three projects: MS SPIDOC, TopSpec, and SuperMaMa all center on mass spectrometry techniques and hardware.
Organization
SPECTROMETRY VISION BV
Dutch SME developing advanced mass spectrometry detectors and instrumentation for protein analysis, antibody profiling, and frontier molecular research.
Technology SMEhealthNLSMENo active H2020 projects
H2020 projects
3
As coordinator
0
Total EC funding
€908K
Unique partners
18
What they do
Their core work
MS Vision is a Dutch SME specializing in advanced mass spectrometry instrumentation and detection technologies. They develop and supply specialized detector systems and mass spectrometry components used in frontier research — from imaging protein complexes with X-ray lasers to superconducting nanowire-based molecule detection. Their work sits at the intersection of precision instrumentation and analytical chemistry, providing hardware and expertise that enables academic and industrial partners to push the boundaries of molecular analysis.
Core expertise
What they specialise in
Superconducting nanowire detectors for molecular analysissecondary
1 project
SuperMaMa project (EUR 369,886) focuses on superconducting mass spectrometry with nanowire detectors for high-mass molecule detection.
Ion mobility and protein conformation analysissecondary
1 project
MS SPIDOC project applied native ion mobility mass spectrometry for conformation-specific imaging of protein complexes.
Antibody and immunotherapeutic profilingemerging
1 project
TopSpec project targeted next-generation precision antibody profiling using tandem mass spectrometry for immunotherapeutics.
Evolution & trajectory
How they've shifted over time
Early focus
Structural protein imaging
Recent focus
Detector innovation and biopharma analytics
MS Vision's early H2020 work (2018) focused on structural biology applications — using mass spectrometry combined with X-ray free-electron lasers to image protein complexes in specific conformations. From 2019 onward, their focus broadened toward practical analytical applications: antibody profiling for immunotherapy and superconducting detector technologies for improved sensitivity. The trajectory shows a shift from purely academic structural biology instrumentation toward detector hardware innovation and biopharma-relevant analytics.
MS Vision is moving toward high-sensitivity detector hardware and life science applications, positioning them as a potential instrumentation partner for biopharma and diagnostic projects.
Collaboration profile
How they like to work
Role: specialist_contributorReach: European8 countries collaborated
MS Vision operates exclusively as a specialist participant — they have never coordinated a project, which is typical for an instrumentation SME contributing specific hardware or technical expertise to larger research consortia. With 18 unique partners across 8 countries in just 3 projects, they join moderately sized, internationally diverse teams. Their role pattern suggests they are brought in for specific technical contributions rather than shaping overall project direction.
Despite only three projects, MS Vision has built a network of 18 partners across 8 countries, indicating they work in broad European consortia typical of FET-funded research. Their connections span multiple research-intensive countries in Europe.
Why partner with them
What sets them apart
MS Vision occupies a rare niche as a private SME building advanced mass spectrometry detection hardware — most competitors in this space are either large instrument manufacturers or university labs. Their involvement in FET (Future and Emerging Technologies) projects signals they work on genuinely frontier instrumentation, not incremental improvements. For consortium builders, they offer the combination of commercial agility with deep technical capability in detector physics and molecular analysis.
Notable projects
Highlights from their portfolio
- MS SPIDOCLargest funded project (EUR 432,500) combining mass spectrometry with X-ray free-electron lasers — an unusual cross-disciplinary combination of analytical chemistry and photon science.
- SuperMaMaExplores superconducting nanowire detectors for mass spectrometry (EUR 369,886), a frontier technology that could dramatically improve detection of very large molecules.
Cross-sector capabilities
Analytical instrumentation and detector hardwareBiopharma and antibody characterizationPhoton science and structural biologyQuantum sensing and superconducting devices
More in Health & Biomedical
See all Health & Biomedical organizations →KOBENHAVNS UNIVERSITET
Denmark's largest research university, excelling in genomics, CRISPR, microbiome science, ancient DNA, and climate research across 696 H2020 projects.
Open →
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France's national biomedical research agency — 400+ H2020 projects spanning neuroscience, infectious disease, cancer, and omics-driven diagnostics.
Open →
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Germany's leading research university in molecular biosciences and translational medicine, with 303 H2020 projects and exceptional ERC grant concentration.
Open →